The FDA has issued warnings about unapproved GLP-1 products that may contain incorrect doses or contaminated ingredients
Semaglutide, a groundbreaking medication initially developed for managing Type 2 diabetes, is making waves in the medical community for its profound impact on blood pressure and lipid profiles
Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study
In most cases, prescriptions cannot be transferred to our pharmacy
Aerobic activities, such as walking, running, and cycling, can enhance heart health, boost metabolism, and improve insulin sensitivity, all contributing to lower triglyceride levels
Competing interests MJD reported board membership and consultancy fees from Novo Nordisk, Sanofi-Aventis, Lilly, Merck, Sharp & Dohme, Boehringer Ingelheim, AstraZeneca, Servier, and Janssen